Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2015

01-03-2015 | Original Article

Treatment Adherence of Diabetic Patients Attending Diabetic Clinic

Authors: Alka Dilip Gore, G. B. Dhumale, U. T. Kumbhar, Y. R. Kadam

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2015

Login to get access

Abstract

Adherence to the treatment of diabetic patients is always a challenge. Hence the study was carried out to find out the effectiveness of the diabetic clinic, in improving the adherence of patients. Study subjects: Patients with known DM attending Diabetic clinic of Medical College Hospital, Sangli. Study design: Cross Sectional study. Study duration: 6 months. Study Tools: Pre tested proforma with written consent of the DM patient. Sampling techniques: all the patients attending diabetic clinic were interviewed once. Sample size: 282. Adherence to pharmacological treatment was 93.3 %, while adherence to non pharmacological treatment, was 78.3 % and 95 % respectively. Statistically highly significant difference was found for the adherence to advice like reducing sugar consumption, in rural and urban patients. Similarly the observed difference was found to be highly significant for the adherence to advice like carrying out daily exercise compared between male and female. Unaffordable drug price was one of the main causes of non-adherence. Adherence to treatment of diabetic patients can be improved with effective and efficient diabetic clinic.
Literature
1.
go back to reference King H, Aubert R, Herman W. Global burden of diabetes, 1995–2025: prevalence, numerical estimates and projections. Diabetes Care. 1998;21:1414–31.CrossRefPubMed King H, Aubert R, Herman W. Global burden of diabetes, 1995–2025: prevalence, numerical estimates and projections. Diabetes Care. 1998;21:1414–31.CrossRefPubMed
2.
go back to reference Kounteya Sinha, TNN, Dec 14, 2011. The Times of India. Kounteya Sinha, TNN, Dec 14, 2011. The Times of India.
3.
go back to reference Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150:1377–78.CrossRefPubMed Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150:1377–78.CrossRefPubMed
4.
go back to reference Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218–24.CrossRefPubMed Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218–24.CrossRefPubMed
5.
go back to reference Mason BJ, Matsuyama JR, Jue SG. Assessment of sulfonylurea adherence and metabolic control. Diabetes Educator. 1995;21:52–7.CrossRefPubMed Mason BJ, Matsuyama JR, Jue SG. Assessment of sulfonylurea adherence and metabolic control. Diabetes Educator. 1995;21:52–7.CrossRefPubMed
6.
go back to reference Martinez YV, Carlos A Prado-Aguilar, Ramon A Rascon-Pacheco and Jose J Valdivia-Martinez. Quality of life associated with treatment adherence in patients with type 2 diabetes: a cross-sectional study. BMC Health Services Research 2008;8:164 Martinez YV, Carlos A Prado-Aguilar, Ramon A Rascon-Pacheco and Jose J Valdivia-Martinez. Quality of life associated with treatment adherence in patients with type 2 diabetes: a cross-sectional study. BMC Health Services Research 2008;8:164
7.
go back to reference Shobhana R, Begum R, Snehalata C, Vijay V, Ramchandran A. Patients’ adherence to diabetes treatment. J Assoc Physicians India. 1999;47:1173–5.PubMed Shobhana R, Begum R, Snehalata C, Vijay V, Ramchandran A. Patients’ adherence to diabetes treatment. J Assoc Physicians India. 1999;47:1173–5.PubMed
8.
go back to reference Cox DJ, Gonder-Frederick L. Major developments in behavioral diabetes research. J Consult Clin Psychol. 1992;60:628–38.CrossRefPubMed Cox DJ, Gonder-Frederick L. Major developments in behavioral diabetes research. J Consult Clin Psychol. 1992;60:628–38.CrossRefPubMed
9.
go back to reference Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.CrossRef
10.
go back to reference Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci. 2011;3:418–23.CrossRefPubMedCentralPubMed Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci. 2011;3:418–23.CrossRefPubMedCentralPubMed
11.
go back to reference Yusuf KB, ObeO, Joseph BY, Adherence to anti-diabetic therapy and self management practices among type-2 diabetics in Nigeria. PHARMACY WORLD & SCIENCE. 30:876–83. Yusuf KB, ObeO, Joseph BY, Adherence to anti-diabetic therapy and self management practices among type-2 diabetics in Nigeria. PHARMACY WORLD & SCIENCE. 30:876–83.
12.
go back to reference Kapur A, Bjork S, Nair J, Kelkar S, Ambady R. Socio-economic determinants of the cost of diabetes in India. Diabetes voice. 2004;49:18–21. Kapur A, Bjork S, Nair J, Kelkar S, Ambady R. Socio-economic determinants of the cost of diabetes in India. Diabetes voice. 2004;49:18–21.
13.
go back to reference Goldman D, Joyce GF, Escarce JJ. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291:2344–50.CrossRefPubMed Goldman D, Joyce GF, Escarce JJ. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291:2344–50.CrossRefPubMed
14.
go back to reference Martin BC, McMillan JA. The impact of implementing a more restrictive prescription limit on Medicaid recipients: effects on cost, therapy, and out-of-pocket expenditures. Medical Care 1996;34:686–701.(cross ref) Martin BC, McMillan JA. The impact of implementing a more restrictive prescription limit on Medicaid recipients: effects on cost, therapy, and out-of-pocket expenditures. Medical Care 1996;34:686–701.(cross ref)
15.
go back to reference Piette JD, Heisler M, Horne R. A conceptually-based approach to understanding chronically-ill patients' responses to medication cost pressures. Social Science and Medicine 2006;62:846–57.(cross ref.) Piette JD, Heisler M, Horne R. A conceptually-based approach to understanding chronically-ill patients' responses to medication cost pressures. Social Science and Medicine 2006;62:846–57.(cross ref.)
16.
go back to reference Mohamed EE. Shams, Mohammed M.H. A1-Gayyar and Enaase A.M.E. Barakat, Type 2 Diabetes Mellitus-Induced Hyperglycemia in Patients with NAFLD and Normal LFTs: relationship to Lipid Profile, Oxidative stress and Pro-Inflammatory Cytokines. Sci Pharm. 2011;79:623–34.CrossRef Mohamed EE. Shams, Mohammed M.H. A1-Gayyar and Enaase A.M.E. Barakat, Type 2 Diabetes Mellitus-Induced Hyperglycemia in Patients with NAFLD and Normal LFTs: relationship to Lipid Profile, Oxidative stress and Pro-Inflammatory Cytokines. Sci Pharm. 2011;79:623–34.CrossRef
17.
go back to reference Ciechanowski PS, Katon WJ, Russo JE, Walker EA. The patient-provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry. 2001;158:29–35.CrossRefPubMed Ciechanowski PS, Katon WJ, Russo JE, Walker EA. The patient-provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry. 2001;158:29–35.CrossRefPubMed
18.
go back to reference DCCT Research Group. Influence of intensive diabetes treatment on quality of life outcomes in the diabetes control and complications trial. Diabetes Care. 1996;19:195–203.CrossRef DCCT Research Group. Influence of intensive diabetes treatment on quality of life outcomes in the diabetes control and complications trial. Diabetes Care. 1996;19:195–203.CrossRef
19.
go back to reference UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
20.
go back to reference Bathgate M, Alexander D, Mitikulena A. The health of Pacific Islands people in New Zealand. Wellington: Public Health Commission; 1994. Bathgate M, Alexander D, Mitikulena A. The health of Pacific Islands people in New Zealand. Wellington: Public Health Commission; 1994.
21.
go back to reference Allen FM, Stillman E, Fitz R: Total dietary regulation in the treatment of diabetes. In Exercise. New York, Rockefeller Inst., 1919, chapt. 5, monogr. 11 Allen FM, Stillman E, Fitz R: Total dietary regulation in the treatment of diabetes. In Exercise. New York, Rockefeller Inst., 1919, chapt. 5, monogr. 11
22.
23.
go back to reference Max W. Simmons, Factors affecting exercise adherence in non-insulin dependent diabetes mellitus sufferers; a thesis submitted to the dept. of psychology, the University of Adelaide, for degree of M.A. Dec. 1989. Max W. Simmons, Factors affecting exercise adherence in non-insulin dependent diabetes mellitus sufferers; a thesis submitted to the dept. of psychology, the University of Adelaide, for degree of M.A. Dec. 1989.
24.
go back to reference Schoenfeld ER, Judith MG, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines; baseline findings from the diabetic retinopathy awareness program. Opthalmology. 2001;108:563–71.CrossRef Schoenfeld ER, Judith MG, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines; baseline findings from the diabetic retinopathy awareness program. Opthalmology. 2001;108:563–71.CrossRef
26.
go back to reference Adherence to long term therapies: evidence for action. Geneva, World Health Organization, 2003. (cross ref) Adherence to long term therapies: evidence for action. Geneva, World Health Organization, 2003. (cross ref)
27.
go back to reference DiMatteo MR. Variations in patient’s adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9.CrossRefPubMed DiMatteo MR. Variations in patient’s adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9.CrossRefPubMed
28.
go back to reference Lacro JP, Dunn LB, Dolder CR. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 2002;63:892–909.(cross ref) Lacro JP, Dunn LB, Dolder CR. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 2002;63:892–909.(cross ref)
29.
go back to reference Johnson SB. Methodological issues in diabetes research, measuring adherence. Diabetes Care. 1992;15:1658–67.CrossRefPubMed Johnson SB. Methodological issues in diabetes research, measuring adherence. Diabetes Care. 1992;15:1658–67.CrossRefPubMed
Metadata
Title
Treatment Adherence of Diabetic Patients Attending Diabetic Clinic
Authors
Alka Dilip Gore
G. B. Dhumale
U. T. Kumbhar
Y. R. Kadam
Publication date
01-03-2015
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2015
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-014-0213-z

Other articles of this Issue 1/2015

International Journal of Diabetes in Developing Countries 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine